Validating DLL3-targeting CAR T in small cell lung cancer

Authors

Bingnan Zhang, The University of Texas MD Anderson Cancer Center
Yan Yang, The University of Texas MD Anderson Cancer Center
Allison Stewart, The University of Texas MD Anderson Cancer Center
Runsheng Wang, The University of Texas MD Anderson Cancer Center
Kavya Ramkumar, The University of Texas MD Anderson Cancer Center
Robert Cardnell, The University of Texas MD Anderson Cancer Center
Azusa Tanimoto, The University of Texas MD Anderson Cancer Center
Ali Ibraham, The University of Texas MD Anderson Cancer Center
Kyle Concannon, The University of Texas MD Anderson Cancer Center
Ben Morris, The University of Texas MD Anderson Cancer Center
Lixia Diao, The University of Texas MD Anderson Cancer Center
Qi Wang, The University of Texas MD Anderson Cancer Center
Jing Wang, The University of Texas MD Anderson Cancer Center
Carl Gay, The University of Texas MD Anderson Cancer Center
John Heymach, The University of Texas MD Anderson Cancer Center
Lauren A. Byers, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00099

Publication Date

2022

Department

Division of Cancer Medicine

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Zhang, Bingnan; Yang, Yan; Stewart, Allison; Wang, Runsheng; Ramkumar, Kavya; Cardnell, Robert; Tanimoto, Azusa; Ibraham, Ali; Concannon, Kyle; Morris, Ben; Diao, Lixia; Wang, Qi; Wang, Jing; Gay, Carl; Heymach, John; and Byers, Lauren A., "Validating DLL3-targeting CAR T in small cell lung cancer" (2022). Leading Edge of Cancer Research Symposium. 23.
doi:https://doi.org/10.52519/00099